skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1405537
Grant/Contract Number:
AC02-05CH11231
Resource Type:
Journal Article: Published Article
Journal Name:
Neuron
Additional Journal Information:
Journal Volume: 92; Journal Issue: 1; Related Information: CHORUS Timestamp: 2017-10-28 16:45:54; Journal ID: ISSN 0896-6273
Publisher:
Elsevier
Country of Publication:
United States
Language:
English

Citation Formats

Silberberg, Shanni N., Taher, Leila, Lindtner, Susan, Sandberg, Magnus, Nord, Alex S., Vogt, Daniel, Mckinsey, Gabriel L., Hoch, Renee, Pattabiraman, Kartik, Zhang, Dongji, Ferran, Jose L., Rajkovic, Aleksandar, Golonzhka, Olga, Kim, Carol, Zeng, Hongkui, Puelles, Luis, Visel, Axel, and Rubenstein, John L. R. Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate. United States: N. p., 2016. Web. doi:10.1016/j.neuron.2016.09.027.
Silberberg, Shanni N., Taher, Leila, Lindtner, Susan, Sandberg, Magnus, Nord, Alex S., Vogt, Daniel, Mckinsey, Gabriel L., Hoch, Renee, Pattabiraman, Kartik, Zhang, Dongji, Ferran, Jose L., Rajkovic, Aleksandar, Golonzhka, Olga, Kim, Carol, Zeng, Hongkui, Puelles, Luis, Visel, Axel, & Rubenstein, John L. R. Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate. United States. doi:10.1016/j.neuron.2016.09.027.
Silberberg, Shanni N., Taher, Leila, Lindtner, Susan, Sandberg, Magnus, Nord, Alex S., Vogt, Daniel, Mckinsey, Gabriel L., Hoch, Renee, Pattabiraman, Kartik, Zhang, Dongji, Ferran, Jose L., Rajkovic, Aleksandar, Golonzhka, Olga, Kim, Carol, Zeng, Hongkui, Puelles, Luis, Visel, Axel, and Rubenstein, John L. R. 2016. "Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate". United States. doi:10.1016/j.neuron.2016.09.027.
@article{osti_1405537,
title = {Subpallial Enhancer Transgenic Lines: a Data and Tool Resource to Study Transcriptional Regulation of GABAergic Cell Fate},
author = {Silberberg, Shanni N. and Taher, Leila and Lindtner, Susan and Sandberg, Magnus and Nord, Alex S. and Vogt, Daniel and Mckinsey, Gabriel L. and Hoch, Renee and Pattabiraman, Kartik and Zhang, Dongji and Ferran, Jose L. and Rajkovic, Aleksandar and Golonzhka, Olga and Kim, Carol and Zeng, Hongkui and Puelles, Luis and Visel, Axel and Rubenstein, John L. R.},
abstractNote = {},
doi = {10.1016/j.neuron.2016.09.027},
journal = {Neuron},
number = 1,
volume = 92,
place = {United States},
year = 2016,
month =
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1016/j.neuron.2016.09.027

Save / Share:
  • No abstract prepared.
  • Transgenic mice carrying a fusion gene in which the mouse immunoglobulin enhancer has been inserted into an otherwise normal human c-myc gene develop a narrow spectrum of pre-B-cell lymphomas. Tumor occurrence is correlated with expression of the transgene in organs in which large numbers of pre-B cells predominate. These tumors, which arise stochastically, are virtually all lymphoblastic lymphomas of the pre-B-cell type. Evidently the isolated enhancer targets oncogene expression and tumorigenesis to the early B-cell population in preference to more mature B-cell populations. The transgene also confers enhanced in vitro growth properties on nontransformed pre-B cells as observed in bonemore » marrow cultures derived from transgenic animals. These cultured cells represent a population in which the activating function of c-myc can be uncoupled from secondary oncogenic events occurring in vivo.« less
  • A transcriptional enhancer element has been identified 4.5 kilobases 3{prime} of C{sub {alpha}} (constant region {alpha} chain) in the human T-cell receptor (TCR) {alpha}-chain locus. This enhancer is active on both a TCR V{sub {alpha}} (variable region {alpha} chain) promoter and the minimal simian virus 40 promoter in TCR {alpha}/{beta} Jurkat and EL4 cells but is inactive on a V{sub {alpha}} promoter TCR {gamma}/{delta} PEER and Molt-13 cells, clone 13 B cells, and HeLa fibroblasts. The enhancer has been localized to a 116-base-pair BstXI/Dra I restriction enzyme fragment, which lacks immunoglobulin octamer and {kappa}B enhancer motifs but does contain amore » consensus cAMP-response element (CRE). DNase I footprint analyses demonstrated that the minimal enhancer contains two binding sites for Jurkat nuclear proteins. One of these sites corresponds to the CRE, while the other does not correspond to a known transcriptional enhancer motif. These data support a model in which TCR {alpha} gene transcription is regulated by a unique set of cis-acting sequences and trans-acting factors, which are differentially active in cells of the TCR {alpha}/{beta} lineage. In addition, the TCR {alpha} enhancer may play a role in activating oncogene expression in T-lymphoblastoid tumors that have previously been shown to display chromosomal translocations into the human TCR {alpha} locus.« less
  • A T-cell-specific transcriptional enhancer was previously identified within the J{sub {delta}3}-C{sub {delta}} intron of the human T-cell receptor (TCR) {delta} gene, and seven distinct binding sites for nuclear factors ({delta}E1 to {delta}E7) were defined by DNase I footprinting. In this study, conducted a detailed functional analysis of the various cis-acting DNA sequence elements of the enhancer and show that a 60-bp fragment encompassing {delta}E3 and {delta}E4 displays potent enhancer activity, as judged by its ability to activate transcription from the V{sub {delta}}1 promoter. They show that the interaction of nuclear factors with the {delta}E3 site is essential for enhancer activity.more » This element displays significant activity in the absence of additional segments of the enhancer. Further, methylation interference and in vitro mutagenesis identify a site within {delta}E3 that mediates the binding of two nuclear factors (NF-{delta}E3A and NF-{delta}E3C) and that is required for significant transcriptional activation by the enhancer. NF-{delta}E3C is ubiquitous and may be identical to a previously characterized {mu}E3-binding factor, NF-{delta}E3A is preferentially expressed in T lymphocytes, and the authors suggest that this factor may play the dominant role in transcriptional activation through the {delta}E3 site. One of three specific complexes formed with a {delta}E4 probe appears to be T-cell specific.« less